John J. Barron, PharmD, Principal Scientist, provides research design guidance on clinical pharmacy topics and relevance to health plan decision makers for HealthCore’s Translational Research for Affordability and Quality team, as well as collaborative projects with life science companies, government agencies and Anthem Inc. Dr. Barron engages with Anthem Clinical Strategy and Policy teams and IngenioRx in the development and conduct of clinical research studies. He serves as a subject matter expert on the design and implementation of pragmatic clinical trials. Dr. Barron is also responsible for collaborating on clinical data strategy efforts for implementation of new data sources used in research.
Dr. Barron specializes in health services and outcomes research, focusing on clinical and economic analyses using large managed care administrative data sets along with clinical data from medical records, disease registries and patient-reported outcomes. The author of a clinical textbook chapter and numerous peer-reviewed articles, Dr. Barron has presented his research findings at conferences nationally and internationally. Dr. Barron also has experience serving as a journal reviewer for several peer-reviewed journals. Dr. Barron’s research has been used by healthcare decision-makers for the development, enhancement and quality improvement of clinical programs, medical policy, clinical pharmacy policy, care management, quality metrics, health and wellness programs, reimbursement support, employer group analyses, public health policy, and benefit design decisions. He has developed a keen insight into the type of data and information that health plans use in their treatment coverage decision making in key areas, such as oncology, cardiology, diabetes, infectious diseases, and respiratory diseases.
Research has shown that people with good oral health generally have better overall health. This white paper outlines Elevance Health activities designed to improve oral health, and the impact these activities can have on overall health and costs.